Moses Rodriguez
#107,847
Most Influential Person Now
Researcher
Moses Rodriguez's AcademicInfluence.com Rankings
Moses Rodriguezcomputer-science Degrees
Computer Science
#3983
World Rank
#4189
Historical Rank
Machine Learning
#648
World Rank
#658
Historical Rank
Artificial Intelligence
#849
World Rank
#865
Historical Rank
Database
#1227
World Rank
#1293
Historical Rank
Download Badge
Computer Science
Moses Rodriguez's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Moses Rodriguez Influential?
(Suggest an Edit or Addition)Moses Rodriguez's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination (2000) (3193)
- A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease (1999) (794)
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis (1996) (764)
- Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls (2016) (596)
- Plasma exchange for severe attacks of CNS demyelination: Predictors of response (2002) (553)
- Multiple sclerosis. (2000) (530)
- A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. (1999) (476)
- Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange (2005) (430)
- Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. (1991) (277)
- The relevance of animal models in multiple sclerosis research. (2011) (269)
- Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis (1983) (263)
- Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. (2000) (258)
- Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000 (2003) (243)
- Immunoglobulins promote remyelination in the central nervous system (1990) (225)
- Optic neuritis (1995) (222)
- Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study (2004) (220)
- Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis (1998) (204)
- Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region (1986) (202)
- Impairment, disability, and handicap in multiple sclerosis (1994) (200)
- A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota (1990) (198)
- Primary demyelination in transgenic mice expressing interferon-γ (1997) (196)
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis (2013) (195)
- Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. (1982) (188)
- Efficient central nervous system remyelination requires T cells (2003) (180)
- Expression of Major Histocompatibility Complex class l Molecules on the Different Cell Types in Multiple Sclerosis Lesions (2004) (177)
- Demyelination induced by Theiler's virus: influence of the H-2 haplotype. (1985) (173)
- Beneficial plasma exchange response in central nervous system inflammatory demyelination. (2011) (172)
- Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease. (2017) (169)
- Indictment of the microglia as the villain in multiple sclerosis (1997) (164)
- Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. (1987) (159)
- Ultrastructure of multiple sclerosis. (1994) (158)
- Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor‐α in the central nervous system (1997) (156)
- Change in MS-related disability in a population-based cohort (2004) (154)
- Risk factors for developing multiple sclerosis after childhood optic neuritis (1997) (153)
- Multifocal inflammatory leukoencephalopathy with 5‐fluorouracil and levamisole (1992) (151)
- The epidemiology of multiple sclerosis. (1997) (149)
- Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. (2004) (147)
- Remyelination in multiple sclerosis (1997) (140)
- Common viruses associated with lower pediatric multiple sclerosis risk (2011) (138)
- Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination (1998) (138)
- Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. (1988) (135)
- Myasthenia gravis in children: Long‐term follow‐up (1983) (133)
- Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination (1993) (130)
- Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. (1993) (128)
- Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. (2000) (127)
- Major histocompatibility complex class II alleles and the course and outcome of MS (1998) (127)
- CD4+ and CD8+ T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis (1998) (126)
- Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. (1994) (126)
- Disability profile of MS did not change over 10 years in a population-based prevalence cohort (2004) (124)
- Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis (2013) (124)
- Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation (2009) (124)
- Gut microbiota composition and relapse risk in pediatric MS: A pilot study (2016) (123)
- Viral perturbation of endocrine function: disordered cell function leads to disturbed homeostasis and disease (1984) (121)
- Oligodendrocyte injury is an early event in lesions of multiple sclerosis. (1993) (120)
- Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS (2017) (118)
- Remyelination by Oligodendrocytes Stimulated by Antiserum to Spinal Cord (1987) (118)
- Perforin-Dependent Neurologic Injury in a Viral Model of Multiple Sclerosis (1998) (118)
- Prevalent Class I-Restricted T-Cell Response to the Theiler’s Virus Epitope Db:VP2121–130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28 (1999) (117)
- Activity of a newly identified serine protease in CNS demyelination. (2002) (115)
- A recombinant human IgM promotes myelin repair after a single, very low dose (2007) (114)
- Younger children with MS have a distinct CSF inflammatory profile at disease onset (2010) (114)
- Partial suppression of Theiler's virus‐induced demyelination in vivo by administration of monoclonal antibodies to immune‐response gene products (Ia antigens) (1986) (113)
- A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis (2005) (113)
- Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus (1991) (112)
- Multiple sclerosis: lessons from neuropathology. (1998) (109)
- Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. (1991) (108)
- Interferon-γ in Progression to Chronic Demyelination and Neurological Deficit Following Acute EAE (1998) (108)
- Seizures in Patients with Multiple Sclerosis (2009) (103)
- Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. (2011) (102)
- Human antibodies accelerate the rate of remyelination following lysolecithin‐induced demyelination in mice (2002) (101)
- Concurrence of inflammatory bowel disease and multiple sclerosis. (2000) (100)
- Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population (2004) (100)
- Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis (1994) (97)
- IV immunoglobulin does not reverse established weakness in MS (2000) (97)
- Relapses and disability accumulation in progressive multiple sclerosis (2015) (96)
- Targeting of IgMκ Antibodies to Oligodendrocytes Promotes CNS Remyelination (1998) (96)
- Surface plasmon resonance for high‐throughput ligand screening of membrane‐bound proteins (2009) (96)
- A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2‐weighted spinal cord MRI in a virus‐induced murine model of MS (2004) (95)
- The Potential for Oligodendrocyte Proliferation During Demyelinating Disease (1993) (95)
- Clinical features of neuromyelitis optica in children (2016) (95)
- A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis (2001) (95)
- Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis (2007) (94)
- Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease (2004) (91)
- Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. (1989) (88)
- Gamma Interferon Is Critical for Neuronal Viral Clearance and Protection in a Susceptible Mouse Strain following Early Intracranial Theiler's Murine Encephalomyelitis Virus Infection (2003) (88)
- The balance between persistent virus infection and immune cells determines demyelination. (1996) (87)
- Immunoglobulins reactive with myelin basic protein promote CNS remyelination (1996) (87)
- Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. (1989) (85)
- Early changes in experimental allergic neuritis. (1983) (84)
- A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis (2001) (84)
- Characteristics of Children and Adolescents With Multiple Sclerosis (2016) (83)
- Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury (1999) (83)
- Gamma interferon is critical for resistance to Theiler's virus-induced demyelination (1995) (82)
- Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. (1980) (80)
- Is Multiple Sclerosis an Autoimmune Disease? (2012) (78)
- Enzymatic properties of rat myelencephalon-specific protease. (2002) (78)
- In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies (2004) (78)
- Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls (2016) (78)
- The treatable dementia of sjögren's syndrome (1991) (77)
- Quantitative Assessment of Neurologic Deficits in a Chronic Progressive Murine Model of CNS Demyelination (1999) (77)
- Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes (1996) (77)
- MRI in Rodent Models of Brain Disorders (2011) (76)
- Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice (1996) (76)
- Interleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury (2003) (76)
- Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair (2003) (76)
- Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. (1991) (75)
- Virus-induced demyelination in mice: "dying back" of oligodendrocytes. (1985) (75)
- Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration (2008) (75)
- Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease (1992) (75)
- CD8+ T cells in multiple sclerosis (2013) (75)
- Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis (2015) (74)
- Association of APOE polymorphisms with disease severity in MS is limited to women (2004) (73)
- A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. (1995) (73)
- Progressive Depletion of Peripheral B Lymphocytes in 4-1BB (CD137) Ligand/I-Eα-Transgenic Mice1 (2001) (73)
- Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic‐progressive demyelinating disease (2002) (72)
- Preservation of motor function by inhibition of CD8+ virus peptide‐specific T cells in Theiler's virus infection (2001) (72)
- Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. (2001) (71)
- Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. (1987) (70)
- Absence of perforin expression confers axonal protection despite demyelination (2007) (70)
- Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network (2014) (68)
- Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic Cells (2002) (68)
- MSP, a trypsin‐like serine protease, is abundantly expressed in the human nervous system (2001) (67)
- Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide (2003) (67)
- Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease (2005) (66)
- Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). (1983) (66)
- Immunotherapeutic Potential of B7-DC (PD-L2) Cross-Linking Antibody In Conferring Antitumor Immunity (2004) (66)
- Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue (1997) (66)
- A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. (2003) (65)
- Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes (2010) (64)
- The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system (1997) (64)
- Trypanosoma cruzi: immunosuppressed response to different antigens in the infected mouse. (1978) (63)
- Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease (2002) (63)
- Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. (1983) (63)
- Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody (2004) (63)
- Multiple Sclerosis (2017) (63)
- Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis. (1994) (61)
- Distinct effects of obesity and puberty on risk and age at onset of pediatric MS (2016) (60)
- Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics. (2013) (59)
- Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis* (2015) (59)
- Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis (2017) (58)
- Not every patient with multiple sclerosis should be treated at time of diagnosis. (2006) (58)
- A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. (2016) (58)
- Autoimmune paraneoplastic cerebellar degeneration (1988) (58)
- Neuron‐Binding Human Monoclonal Antibodies Support Central Nervous System Neurite Extension (2004) (58)
- Distinct promoters regulate tissue‐specific and differential expression of kallikrein 6 in CNS demyelinating disease (2004) (57)
- Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis. (2000) (57)
- Microangiopathy of vasa nervorum in dysglobulinemic neuropathy (1984) (56)
- Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. (1990) (56)
- Multiple sclerosis, seizures, and antiepileptics: role of IL‐18, IDO, and melatonin (2011) (56)
- Disrupted spatial memory is a consequence of picornavirus infection (2006) (55)
- Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis (2002) (55)
- Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study (2012) (55)
- Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis (1997) (55)
- Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice (1990) (55)
- Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome. (2006) (54)
- PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation (2013) (53)
- Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells (2019) (53)
- Dietary salt intake and time to relapse in paediatric multiple sclerosis (2016) (53)
- Advances in Experimental Medicine and Biology (2012) (53)
- Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells 1 (2003) (53)
- Chemokine Expression in the Central Nervous System of Mice with a Viral Disease Resembling Multiple Sclerosis: Roles of CD4+ and CD8+ T Cells and Viral Persistence (2002) (53)
- The controversy surrounding the pathogenesis of the multiple sclerosis lesion. (1997) (53)
- Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. (2009) (52)
- Direct observation of myelination in vivo in the mature human central nervous system. A model for the behaviour of oligodendrocyte progenitors and their progeny. (1997) (52)
- Humoral autoimmunity as a mediator of CNS repair (2001) (52)
- Multifocal inflammatory leukoencephalopathy associated with levamisole therapy (1995) (52)
- Ebola virus: Melatonin as a readily available treatment option (2015) (51)
- Multiple sclerosis update. (2002) (51)
- Multiple Sclerosis: Basic Concepts and Hypothesis (1989) (51)
- H-2 Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. (1995) (50)
- Health care utilization in multiple sclerosis (1998) (50)
- Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990-1998. (2001) (50)
- Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis (2020) (50)
- Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination (1986) (50)
- Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. (2000) (50)
- Potential scope of action of tissue kallikreins in CNS immune-mediated disease (2006) (49)
- Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. (1998) (48)
- Immune-mediated injury of virus-infected oligodendrocytes A model of multiple sclerosis. (1986) (48)
- Dynamic role of kallikrein 6 in traumatic spinal cord injury (2006) (48)
- Facile assembly of micro- and nanoarrays for sensing with natural cell membranes. (2011) (48)
- Direct Comparison of Demyelinating Disease Induced by the Daniel's Strain and BeAn Strain of Theiler's Murine Encephalomyelitis Virus (2003) (48)
- Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II‐transgenic mice (2004) (47)
- Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals (2005) (47)
- Immunomodulation using the recombinant monoclonal human B7‐DC cross‐linking antibody rHIgM12 (2006) (47)
- Hit-hit and hit-run: Viruses in the playing field of multiple sclerosis (2003) (47)
- Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic (1989) (47)
- Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody (1997) (47)
- Demyelinated Axons and Motor Function Are Protected by Genetic Deletion of Perforin in a Mouse Model of Multiple Sclerosis (2009) (46)
- VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. (1995) (45)
- Differential generation of class I H‐2D‐ versus H‐2K‐restricted cytotoxicity against a demyelinating virus following central nervous system infection (1997) (44)
- Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. (2000) (44)
- Growth factor treatment of demyelinating disease: at last, a leap into the light. (2002) (44)
- Invited Article: Human natural autoantibodies in the treatment of neurologic disease (2009) (44)
- Enhancing CNS Repair in Neurological Disease (2011) (44)
- Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. (2001) (44)
- Contrasting effects of IFNβ and IVIG in children with central and peripheral demyelination (2003) (44)
- CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination (2007) (43)
- Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice. (1992) (43)
- Demyelination and Remyelination in Murine Viral Encephalomyelitis a (1984) (43)
- Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. (1993) (43)
- Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination (1995) (42)
- Interferon α/β mediates early virus-induced expression of H-2D and H-2K in the central nervous system (1997) (42)
- Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. (1990) (42)
- Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. (1998) (42)
- Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice. (2012) (42)
- Proteolipid Protein Gene Expression in Demyelination and Remyelination of the Central Nervous System: A Model for Multiple Sclerosis (1994) (42)
- Effects of Transforming Growth Factor‐β and Platelet‐Derived Growth Factor on Oligodendrocyte Precursors: Insights Gained from a Neuronal Cell Line (1997) (42)
- Strains from both Theiler's virus subgroups encode a determinant for demyelination (1990) (40)
- Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination (2010) (40)
- TGF-β2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis1 (2000) (40)
- Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry (2019) (40)
- A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens (1996) (40)
- More severe neurologic deficits in SJL/J male than female mice following Theiler’s virus-induced CNS demyelination (2003) (40)
- Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. (2006) (39)
- Central neurogenic hyperventilation in an awake patient with brainstem astrocytoma (1982) (39)
- Differential Influence of Interleukin-12 in the Pathogenesis of Autoimmune and Virus-Induced Central Nervous System Demyelination (1999) (39)
- Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US (2018) (38)
- Surgical therapy for tremor in multiple sclerosis (2001) (38)
- HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice (2005) (38)
- Acute hemorrhagic demyelination in a murine model of multiple sclerosis (2008) (38)
- Update on the epidemiology of multiple sclerosis. (1989) (37)
- Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis (2012) (36)
- Antigen-Specific CD8+ T Cells Mediate a Peptide-Induced Fatal Syndrome1 (2005) (36)
- CD8+ T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis (2010) (35)
- Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease (1992) (35)
- Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis (2018) (35)
- Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis (2012) (35)
- Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. (1988) (34)
- Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapy. (2002) (34)
- A unique population of circulating autoantibodies promotes central nervous system remyelination (1998) (34)
- Preferential expression of myelencephalon‐specific protease by oligodendrocytes of the adult rat spinal cord white matter (2000) (34)
- HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice 1 (2009) (34)
- Genetic risk factors for pediatric-onset multiple sclerosis (2018) (34)
- Autoantibodies with enzymatic properties in human autoimmune diseases. (2011) (34)
- Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. (1999) (34)
- Central Nervous System Remyelination Clinical Application of Basic Neuroscience Principles (1996) (34)
- High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. (2012) (33)
- Multiple sclerosis: the role of melatonin and N-acetylserotonin. (2015) (33)
- HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-γ1 (2008) (33)
- Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis (2020) (33)
- Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis (2013) (33)
- Internalization and Sorting of Plasma Membrane Sphingolipid Analogues in Differentiating Oligodendrocytes (1999) (33)
- Age is a critical determinant in recovery from multiple sclerosis relapses (2018) (33)
- Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses (1992) (33)
- A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis (2015) (32)
- A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. (1999) (32)
- Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells (2010) (32)
- Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis (1997) (32)
- Role of T cells in resistance to Theiler's virus infection☆ (1991) (32)
- Ultrastructural, Morphometric, and Immunocytochemical Study of Anterior Hom Cells in Mice with “Wasted” Mutation (1989) (32)
- Trauma and multiple sclerosis (1993) (31)
- Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination (2004) (31)
- Polyclonal and monoclonal antibodies in clinic. (2014) (31)
- Mechanisms of Disease and Strategies for Myelin and Axonal Repair (31)
- Pituitary dwarfism in mice persistently infected with lymphocytic choriomeningitis virus. (1983) (31)
- Improvement of myelopathy in Sjögren’s syndrome with chlorambucil and prednisone therapy (1999) (31)
- Antibody-mediated remyelination operates through mechanism independent of immunomodulation (2004) (30)
- Animal models of demyelination (1996) (30)
- Short‐term treatment with interferon‐α/β promotes remyelination, whereas long‐term treatment aggravates demyelination in a murine model of multiple sclerosis (2000) (30)
- Immunoglobulin-mediated CNS repair. (2001) (30)
- Magnetic resonance imaging and clinical relationships in multiple sclerosis. (1987) (30)
- A human IgM signals axon outgrowth: coupling lipid raft to microtubules (2011) (30)
- Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis (2011) (29)
- The tubulin genes of Trypanosoma cruzi. (1988) (29)
- Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial. (1994) (29)
- Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a (2004) (29)
- A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. (1996) (29)
- Absence of IFN-γ Increases Brain Pathology in Experimental Autoimmune Encephalomyelitis–Susceptible DRB1*0301.DQ8 HLA Transgenic Mice through Secretion of Proinflammatory Cytokine IL-17 and Induction of Pathogenic Monocytes/Microglia into the Central Nervous System (2014) (29)
- Cellular sources and targets of IFN‐γ‐mediated protection against viral demyelination and neurological deficits (2002) (29)
- Canine GM1 Gangliosidosis: An Ultrastructural and Biochemical Study (1982) (29)
- Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. (2008) (28)
- Analysis of sites of foot and mouth disease virus persistence in carrier cattle via the polymerase chain reaction (2005) (28)
- Genetically Dominant Spinal Cord Repair in a Murine Model of Chronic Progressive Multiple Sclerosis (2005) (28)
- Improved relapse recovery in paediatric compared to adult multiple sclerosis. (2020) (28)
- Anatomical and Cellular Requirements for the Activation and Migration of Virus-Specific CD8+ T Cells to the Brain during Theiler's Virus Infection (2005) (28)
- HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. (2003) (28)
- Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity (2015) (27)
- Human Monoclonal IgM Antibody Promotes CNS Myelin Repair Independent of Fc Function (2003) (27)
- Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus-induced demyelination in the mouse. (1998) (27)
- Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. (1990) (26)
- Characterization of immunologic and neuropathologic abnormalities in wasted mice. (1987) (26)
- Virus-induced demyelination in mice (1985) (26)
- Tumor Necrosis Factor α is Reparative via TNFR1 in the Hippocampus and via TNFR2 in the Striatum after Virus‐Induced Encephalitis (2009) (26)
- Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies (1989) (26)
- Incidence of seizures in patients with multiple sclerosis: a population-based study. (2002) (25)
- Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin. (2006) (25)
- Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease (2015) (25)
- Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis. (1992) (25)
- Spontaneous and induced remyelination in multiple sclerosis and the theiler's virus model of central nervous system demyelination (1995) (25)
- Membrane lymphotoxin is required for resistance to Theiler's virus infection. (2003) (24)
- Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis? (2017) (24)
- Identification of multiple sclerosis-associated genes. (1997) (24)
- Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis (2013) (24)
- Transgenic Expression of Theiler's Murine Encephalomyelitis Virus Genes in H-2b Mice Inhibits Resistance to Virus-Induced Demyelination (2002) (24)
- Molecular characterization of South American bovine herpesvirus-1 isolates with monoclonal antibodies and SDS-PAGE. (1993) (24)
- Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy (2011) (24)
- Experimental strategies to promote central nervous system remyelination in multiple sclerosis: Insights gained from the Theiler's virus model system (1995) (24)
- Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin. (2016) (24)
- Urban air quality and associations with pediatric multiple sclerosis (2018) (24)
- Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations. (1985) (23)
- Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response. (1995) (23)
- Treatment of multiple sclerosis in children and adolescents (2010) (23)
- 5-Fluorouracil and Levamisole Exacerbate Demyelination in Susceptible Mice Infected with Theiler's Virus (1997) (23)
- Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes. (1995) (23)
- Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseases (2014) (23)
- Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain). (1988) (23)
- Magnetic resonance imaging of immune cells in inflammation of central nervous system. (2003) (23)
- Blockade of Allergic Airway Inflammation Following Systemic Treatment with a B7-Dendritic Cell (PD-L2) Cross-Linking Human Antibody1 (2004) (23)
- Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1β (2006) (23)
- AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage–Th17 Axis (2016) (23)
- A Single Dose of Neuron-Binding Human Monoclonal Antibody Improves Spontaneous Activity in a Murine Model of Demyelination (2011) (23)
- Extensive Injury of Descending Neurons Demonstrated by Retrograde Labeling in a Virus‐Induced Murine Model of Chronic Inflammatory Demyelination (2000) (22)
- Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. (2012) (22)
- Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response (2014) (21)
- Method of Identifying Natural Antibodies for Remyelination (2010) (21)
- Subacute encephalomyelitis presenting as stiff‐person syndrome: Clinical, polygraphic, and pathologic correlations (1996) (21)
- Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelination (2000) (21)
- CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system (1998) (21)
- Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination. (1991) (21)
- Dietary factors and pediatric multiple sclerosis: A case-control study (2018) (21)
- Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: Marker of demyelination and repair in spinal cord (2009) (21)
- Immune promotion of central nervous system remyelination. (1994) (21)
- The US Network of Pediatric Multiple Sclerosis Centers (2015) (21)
- IgM Natural Autoantibodies in Physiology and the Treatment of Disease. (2018) (20)
- Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis (2016) (20)
- Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice (2015) (20)
- Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC. (2006) (20)
- Antiviral Effects of a Transgenic RNA-Dependent RNA Polymerase (2010) (20)
- Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination. (2002) (20)
- Expression of T cell receptor Vβ transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination (1993) (20)
- Protective environmental factors for neuromyelitis optica (2014) (20)
- Contrasting murine models of MS. (2004) (19)
- Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection (2005) (19)
- Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. (2000) (19)
- The role of cellular immune response in Theiler's virus-induced central nervous system demyelination (2004) (19)
- Antibody-mediated Remyelination: Relevance to Multiple Sclerosis (2000) (19)
- Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? (1999) (19)
- Advances in multiple Sclerosis and Experimental Demyelinating Diseases (2008) (19)
- CD40L is Critical for Protection from Demyelinating Disease and Development of Spontaneous Remyelination in a Mouse Model of Multiple Sclerosis (2000) (18)
- Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline (2019) (18)
- Retraction: Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells (2003) (18)
- Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line. (1997) (18)
- Disappearing "T1 black holes" in an animal model of multiple sclerosis. (2004) (18)
- The Spectrum of Inflammatory Acquired Demyelinating Syndromes in Children. (2017) (18)
- Have we finally identified an autoimmune demyelinating disease? (2009) (18)
- Heterogeneity in association of remote herpesvirus infections and pediatric MS (2018) (18)
- Neurotrophin-4/5 promotes proliferation of oligodendrocyte-type-2 astrocytes (O-2A). (2000) (18)
- Pulsed intravenous methylprednisolone therapy in progressive multiple sclerosis: need for a controlled trial. (2004) (18)
- Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system. (1997) (18)
- Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders (2015) (17)
- Examining the contributions of environmental quality to pediatric multiple sclerosis. (2017) (17)
- Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease (2008) (17)
- Vitamin D genes influence MS relapses in children (2020) (17)
- Molecular Characterization of a Nondemyelinating Variant of Daniel’s Strain of Theiler’s Virus Isolated from a Persistently Infected Glioma Cell Line (1998) (17)
- Genetic Deletion of a Single Immunodominant T‐cell Response Confers Susceptibility to Virus‐induced Demyelination (2007) (17)
- Abbreviated Exposure to Hypoxia Is Sufficient to Induce CNS Dysmyelination, Modulate Spinal Motor Neuron Composition, and Impair Motor Development in Neonatal Mice (2015) (17)
- Theiler's virus-associated antigens on the surfaces of cultured glial cells. (1988) (17)
- Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases. (2015) (17)
- Allelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair (2009) (16)
- TREM-2 Mediated Signaling Induces Antigen Uptake and Retention in Mature Myeloid Dendritic Cells1 (2008) (16)
- Role of MHC class II expressing CD4+ T cells in proteolipid protein91–110‐induced EAE in HLA‐DR3 transgenic mice (2006) (16)
- Persistence of Theiler's Virus Infection Following Promotion of Central Nervous System Remyelination (1991) (16)
- Transgenic Expression of the 3D Polymerase Inhibits Theiler's Virus Infection and Demyelination (2009) (16)
- Human-derived natural antibodies: biomarkers and potential therapeutics. (2015) (16)
- A patterned recombinant human IgM guides neurite outgrowth of CNS neurons (2013) (16)
- TGF-beta 2 reduces demyelination, virus antigen expression, and macrophage recruitment in a viral model of multiple sclerosis. (2000) (15)
- Method to detect asymptomatic carriers of simian hemorrhagic fever virus. (1980) (15)
- Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire (2013) (15)
- Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis (1998) (15)
- Motor and somatosensory evoked potentials in mice infected with Theiler's murine encephalomyelitis virus (1994) (15)
- Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression. (2016) (15)
- Multiple sclerosis: insights into molecular pathogenesis and therapy. (1997) (15)
- Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. (1998) (15)
- Promotion of endogeneous remyelination in Multiple Sclerosis (1997) (14)
- Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis. (1996) (14)
- The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. (2000) (14)
- Surgical therapy for tremor in multiple sclerosis: An evaluation of outcome measures (2001) (14)
- Human class I major histocompatibility complex transgene prevents virus‐induced demyelination in susceptible mutant B 10.d2dml mice (1993) (14)
- Deletion of Beta‐2‐Microglobulin Ameliorates Spinal Cord Lesion Load and Promotes Recovery of Brainstem NAA Levels in a Murine Model of Multiple Sclerosis (2012) (14)
- Simian haemorrhagic fever (SHF): new virus isolate from a chronically infected patas monkey. (1980) (14)
- Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition (2020) (13)
- Gut microbiome is associated with multiple sclerosis activity in children (2021) (13)
- Transgenic Expression of Viral Capsid Proteins Predisposes to Axonal Injury in a Murine Model of Multiple Sclerosis (2011) (13)
- Humoral autoimmunity as a mediator of CNS repair (2001) (13)
- STAT4‐ and STAT6‐signaling molecules in a murine model of multiple sclerosis (2006) (13)
- A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis (2015) (12)
- A monoclonal natural human IgM protects axons in the absence of remyelination (2016) (12)
- The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment (2013) (12)
- The progeroid gene BubR1 regulates axon myelination and motor function. (2016) (12)
- Antigenic variants are not selected during persistent infection with Theiler's virus (1983) (12)
- Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination (1997) (12)
- Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls (1990) (12)
- CNS Cell Populations are Protected from Virus‐Induced Pathology by Distinct Arms of the Immune System (1999) (12)
- Need for a paradigm shift in therapeutic approaches to CNS injury (2012) (12)
- Influence of deletion of T cell receptor V beta genes on the Theiler's virus model of multiple sclerosis. (1994) (11)
- Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy (2019) (11)
- Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis (2012) (11)
- Immunosuppressive treatment of multiple sclerosis. (1989) (11)
- Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis. (1991) (10)
- Increased hepatotropism of mutants of MHV, strain JHM, selected with monoclonal antibodies. (1987) (10)
- The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. (1997) (10)
- Enhancing Central Nervous System Repair-The Challenges (2011) (10)
- Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel’s (DA) strain of Theiler’s virus (1996) (10)
- Vβ8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis (2000) (10)
- A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next? (2018) (10)
- Retraction: Blockade of Allergic Airway Inflammation Following Systemic Treatment with a B7-Dendritic Cell (PD-L2) Cross-Linking Human Antibody (2004) (10)
- MRI findings in benign multiple sclerosis are variable (2007) (10)
- Statin therapy and multiple sclerosis disability in a population-based cohort (2012) (10)
- Virus-Induced Demyelination (1984) (10)
- HLA-DQ Polymorphism Influences Progression of Demyelination and Neurologic Deficits in a Viral Model of Multiple Sclerosis (2000) (10)
- CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice. (2004) (9)
- Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone (1997) (9)
- A New Humanized HLA Transgenic Mouse Model of Multiple Sclerosis Expressing Class II on Mouse CD4 T Cells (2007) (9)
- Dysglobulinemic neuropathy: Absence of immunoglobulin within myelin sheaths (1986) (9)
- Virologic models of chronic relapsing demyelinating disease. (1983) (9)
- Novel Roles of the Picornaviral 3D Polymerase in Viral Pathogenesis (2010) (9)
- The Contribution of MHC Gene Products to Demyelination by Theiler’s Virus (1987) (9)
- miRNA contributions to pediatric‐onset multiple sclerosis inferred from GWAS (2019) (9)
- A 40‐cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis (2003) (8)
- ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination (2002) (8)
- Antigens to viral capsid and non-capsid proteins are present in brain tissues and antibodies in sera of Theiler's virus-infected mice. (2001) (8)
- Detection of bovine herpesvirus type 1 via an immunoperoxidase method, using monoclonal antibodies. (1989) (8)
- Glial cells as therapeutic targets in progressive multiple sclerosis (2019) (8)
- Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis. (2017) (8)
- Gut microbiome in early pediatric multiple sclerosis: a case-control study (P4.027) (2015) (8)
- Plasmonic nanohole arrays for label-free kinetic biosensing in a lipid membrane environment (2009) (7)
- Multiple sclerosis: a unique immunopathological syndrome of the central nervous system (2004) (7)
- Localization of foot and mouth disease virus RNA in tissue culture infected cells via in situ polymerase chain reaction. (1995) (7)
- AUTOIMMUNE CEREBELLAR DEGENERATION ASSOCIATED WITH CANCER: LOCALIZATION OF PURKINCE CYTOPLASMIC ANTIGEN BY IMMUNO-ELECTRON MICROSCOPY (1986) (7)
- CD 4 1 and CD 8 1 T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis (1998) (7)
- Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population (2017) (7)
- Rapid diagnosis of bovine herpesvirus encephalitis: comparison of nucleic acid hybridization and immunoperoxidase methods using clinical samples. (1988) (7)
- Pediatric Multiple Sclerosis Severity Score in a large US cohort (2020) (7)
- Several household chemical exposures are associated with pediatric‐onset multiple sclerosis (2018) (7)
- Remyelination as Neuroprotection (2005) (7)
- Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis. (2014) (7)
- The progeroid gene BubR1 regulates axon myelination and motor function (2016) (6)
- Nonequivalence of Classical MHC Class I Loci in Ability to Direct Effective Antiviral Immunity (2012) (6)
- Relapse recovery (2019) (6)
- Histopathology in the Theiler’s Virus Model of Demyelination (2005) (6)
- Mechanisms of Virus‐Induced Demyelination and Remyelinationa (1988) (6)
- Association Between Time Spent Outdoors and Risk of Multiple Sclerosis (2021) (6)
- Treatment of Acute Exacerbations of Multiple Sclerosis (2013) (6)
- Naturally occurring antibodies as therapeutics for neurologic disease: can human monoclonal IgMs replace the limited resource IVIG? (2012) (6)
- Nucleic acid hybridisation and polymerase chain reaction in the diagnosis of infectious animal diseases. (1993) (6)
- Influences of the microenvironment on B-cell responses of wasted mice: comparison of Peyer's patches and mesenteric lymph nodes. (1988) (6)
- The immunopathology of multiple sclerosis (1991) (6)
- Increased body mass index is causally associated with pediatric MS onset: A Mendelian randomization study (P1.375) (2016) (5)
- Enumeration and Distribution of T‐Cell Subsets, Macrophages, and IgG Positive Cells in the CNS of SJL/J Mice Infected with Theiler's Virus a (1988) (5)
- Anti-mu treatment suppresses immunoglobulin light-chain gene expression and Peyer's patch development. (1989) (5)
- Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis (2016) (5)
- Demyelination with preferential MAG loss: A complex message from MS paraffin blocks (2018) (5)
- Rapid weaning from mechanical ventilator in acute cervical cord multiple sclerosis lesion after steroids. (2001) (5)
- Lipid-specific IgMs induce antiviral responses in the CNS: implications for progressive multifocal leukoencephalopathy in multiple sclerosis (2020) (5)
- First Genome-Wide Analysis in Pediatric Multiple Sclerosis (MS) Confirms a Role for Adult MS Risk Variants and Reveals New Candidates (S29.001) (2016) (5)
- 63 FURTHER STUDIES ON THE PATHOGENESIS OF THEILERʼS MURINE ENCEPHALOMYELITIS (1983) (5)
- Aspirin is Unlikely to Have A Clinically Meaningful Effect on Multiple Sclerosis-Related Fatigue: Data From a Randomized Controlled Trial (P7.245) (2014) (4)
- Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials (2021) (4)
- TGF-b2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis (2000) (4)
- Viral perturbation of endocrine function (1984) (4)
- Human HLA-DR Transgenes Protect Mice from Fatal Virus-Induced Encephalomyelitis and Chronic Demyelination (2008) (4)
- Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide91–110 and critical residues required for induction of EAE in HLA-DR3 transgenic mice (2005) (4)
- Experimental Models of Virus-Induced Demyelination (2004) (4)
- Inability of bm14 Mice to Respond to Theiler’s Murine Encephalomyelitis Virus Is Caused by Defective Antigen Presentation, Not Repertoire Selection1 (2005) (4)
- Disease Modifying Therapies in Multiple Sclerosis (2013) (4)
- Trypanosoma cruzi: altered parasites after in vitro treatment with gangliosides, a therapeutic agent in experimental Chagas' disease. (2009) (4)
- Surface Plasmon Resonance Sensing on Naturally Derived Membranes: A Remyelination-Promoting Human Antibody Binds Myelin with Extraordinary Affinity. (2018) (4)
- A case-control study of dietary salt intake and risk of pediatric multiple sclerosis (MS) (S38.003) (2015) (3)
- The Repair of Central Nervous System Myelin (1997) (3)
- Identification of Multiple Sclerosis-Associated Associated Genes (1997) (3)
- An Assay that Predicts In Vivo Efficacy for DNA Aptamers that Stimulate Remyelination in a Mouse Model of Multiple Sclerosis (2018) (3)
- Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study (2013) (3)
- Dalfampridine for the treatment of ambulatory impairment in multiple sclerosis (2010) (3)
- Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis (2019) (3)
- Curvature Elasticity‐Driven Leaflet Asymmetry and Interleaflet Raft Coupling in Supported Membranes (2018) (3)
- Physical trauma and multiple sclerosis: Reply from the authors (1994) (2)
- Differentiation-specific mRNA expression of a mouse bipotential glial cell line (1998) (2)
- Receptor–ligand interactions underlying RBC invasion in Babesia (2015) (2)
- Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis (2022) (2)
- V(beta)8(+) T cells protect from demyelinating disease in a viral model of multiple sclerosis. (2000) (2)
- Antibody-mediated oligodendrocyte remyelination protects axons and restores axonal transport in progressive demyelinating disease (2015) (2)
- Impact of the radiated brain microenvironment on a panel of human patient-derived xenografts (2020) (2)
- Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis (2021) (2)
- Immunoglobulin gene expression in wasted mice. (1987) (2)
- Nanogap dielectrophoresis combined with buffer exchange for detecting protein binding to trapped bioparticles (2020) (2)
- Antibody characterization using immunosignatures (2020) (2)
- Remyelination-Promoting DNA Aptamer Conjugate Myaptavin-3064 Binds to Adult Oligodendrocytes In Vitro (2020) (2)
- ISOLATION OF INFLAMMATORY CELLS FROM CNS OF MICE INFECTED PERSISTENTLY WITH THEILER'S VIRUS: 111 (1987) (1)
- Mice Encephalomyelitis in HLA-DR 3-Transgenic Cells Exacerbate Experimental Autoimmune HLA-DQ 8 ( DQB 1 * 0302 )-Restricted (2009) (1)
- Stimulation by Dendritic Cells That Binds B7-DC and Potentiates T Cell Naturally Occurring Human IgM Antibody (2013) (1)
- The Differential Diagnosis of Multiple Sclerosis (2013) (1)
- Multiple sclerosis and seizures: possible role for Helicobacter pylori (2011) (1)
- Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression. (2017) (1)
- Profile of circulatory metabolites in chronic mouse model of multiple sclerosis using untargeted global metabolomics (THER3P.883) (2014) (1)
- Immunopathology of Theiler's virus-induced demyelination (1987) (1)
- Formation of biomembrane microarrays with a squeegee-based assembly method. (2014) (1)
- Dietary Factors and Risk of Pediatric Multiple Sclerosis (S29.006) (2016) (1)
- Demyelinating Disorders of the Central Nervous System in Childhood: Disease-modifying therapy and response to first-line treatment in pediatric multiple sclerosis (2011) (1)
- Retraction: Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity. (2010) (1)
- A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients. (2015) (1)
- RESISTANCE TO THEILERʼS MURINE ENCEPHALOMYELITIS VIRUS (TMEV)-INDUCED DEMYELINATION IS INHERITED AS A DOMINANT TRAIT IN BIO CONGENIC MICE: 68 (1989) (1)
- 65 THEILERʼS MURINE ENCEPHALOMYELITIS VIRUS (TMEV) INDUCED DEMYELINATING DISEASE: EFFECT OF TREATMENT WITH MYELIN COMPONENTS (1984) (1)
- Longitudinal Evaluation of Cognitive Functioning in Pediatric Multiple Sclerosis (MS): Report from the U.S. Pediatric Multiple Sclerosis Network (S33.004) (2014) (1)
- Promising Directions in Relapse-Impact Prevention in Multiple Sclerosis Current immunomodulatory treatments for MS are not reliable to prevent long-term disability , but future agents focusing on remyelination and axonal and neuronal repair could reverse this course (1)
- A natural human monoclonal antibody protects from axonal injury in different CNS degenerative disease models (2018) (1)
- Effect of Obesity and Puberty on Risk and Age at Onset of Pediatric MS (S29.003) (2016) (1)
- HLA-DQ6 (DQB1*0601) molecule modulate PLPp91-110 induced EAE in DR3 (DRB1*0301) mice through apoptosis. (130.6) (2007) (1)
- Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy? (2019) (1)
- Imaging of multiple sclerosis and related acquired demyelinating disorders in childhood (2013) (1)
- Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. (2018) (1)
- Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study (2016) (1)
- A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse (2022) (1)
- FP30-WE-04 Genetic determinants of CNS repair following chronic demyelination in mice (2009) (1)
- BLACK HOLES ” IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS (2003) (1)
- What Has Immunology Taught Us About Multiple Sclerosis (2013) (0)
- Low doses of IgM antibodies for treatment of demyelinating disorders (2004) (0)
- Erratum: Tumor necrosis factor α is reparative via TNFR1 in the hippocampus and via TNFR2 in the striatum after virus-induced encephalitis (Brain Pathology (2009) 19 (12-26)) (2011) (0)
- MOG and Aquaporin-4 Antibody Frequency, Clinical and MRI Characteristics, and Disease Course Among Children Diagnosed with MS and Controls (2021) (0)
- Lipid Membranes: Curvature Elasticity‐Driven Leaflet Asymmetry and Interleaflet Raft Coupling in Supported Membranes (Adv. Mater. Interfaces 23/2018) (2018) (0)
- Interferon Treatment of Neurologic Disorders (1989) (0)
- Longitudinal Cognitive Screening Findings in Pediatric MS vs. Pediatric Controls and Adult MS in a Multi-center Cohort (S31.008) (2023) (0)
- Human class I major histocompatibility complex alleles determine central nervous system injury versus repair (2016) (0)
- Nontargeted urinary metabolite profiling of a chronic mouse model of multiple sclerosis (THER3P.884) (2014) (0)
- Gut microbiota dysbiosis in patients with Multiple Sclerosis (2016) (0)
- AMPK, a metabolic enzyme, negatively regulate EAE by modulating IL17 response (148.20) (2011) (0)
- Clinical and Demographic Features of Children with NMO: Report from the U.S. Network of Pediatric MS Centers of Excellence (S63.003) (2014) (0)
- Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity (2022) (0)
- Viral and Genetic Risk Factors for Pediatric Neuromyelitis Optica (P02.114) (2013) (0)
- Table 1, Human monoclonal IgMs isolated from EBV immortalized B cell lines promote CNS remyelination (2013) (0)
- Disability does not change substantially for most multiple sclerosis patients over a decade in a population-based cohort (2003) (0)
- A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis (2015) (0)
- SERA OF MICE HYPERIMMUNIZED WITH MYELIN COMPONENTS PROMOTE CNS REMYELINATION IN CHRONIC THEILERʼS VIRUS ENCEPHALOMYELITIS (1985) (0)
- Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression. (2015) (0)
- a recombinant human Igm crosses blood brain barrier, promotes survival and protects spinal cord anterior horn cells in two transgenic murine models of amyotrophic lateral sclerosis : sun-074 (2014) (0)
- Allergies in Pediatric Multiple Sclerosis: A Case-Control Study (P1.380) (2016) (0)
- Gene–environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures (2023) (0)
- Pathogenesis ofEarlyandLateDisease inMiceInfected with Theiler's Virus, UsingIntratypic Recombinant GDVII/DAViruses (1992) (0)
- Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2 (2023) (0)
- Fat, fiber, and pediatric MS (S38.002) (2015) (0)
- 2009 ACTRIMS ABSTRACTS: Oral Presentations (2009) (0)
- or Major Myelin Antigenic Specificity System-Infiltrating CTLs with no Apparent Viral Susceptible Mice Induces Central Nervous Theiler's Virus Infection of Genetically (1998) (0)
- MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls (2022) (0)
- The Role of Magnetic Resonance Imaging in Multiple Sclerosis (2013) (0)
- Impaired Cognition without Behavioral Problems in Pediatric Clinically Isolated Syndrome (CIS) (P02.113) (2013) (0)
- Retraction: TREM-2 Mediated Signaling Induces Antigen Uptake and Retention in Mature Myeloid Dendritic Cells (2010) (0)
- Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US (P14-3.008) (2023) (0)
- Retrograde axonal transport reduction during CNS demyelination in Theiler's virus-infected mice (1998) (0)
- Chapter 13 Treatment of Catastrophic Multiple Sclerosis (2003) (0)
- Newer drug therapies for multiple sclerosis (1990) (0)
- IN24-TU-03 Repair strategies in multiple sclerosis (2009) (0)
- DEMYELINATION CAN BE INDUCED IN CLASS II DEFICIENT MICE: 27 (1995) (0)
- Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis (2012) (0)
- Human class I major histocompatibility complex alleles determine central nervous system injury versus repair (2016) (0)
- Multiple Sclerosis (Butterworths International Medical Reviews, Neurology, Vol 6), W. Ian McDonald, Donald H. Silberberg (Eds.). Massachusetts, Butterworth Publishers, Stoneham (1986), 193, with illus, $39.95 (1986) (0)
- Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease (2015) (0)
- The Epidemiology of Multiple Sclerosis, Genetics, and Environment (2013) (0)
- Characteristics and Predictors of Disease Course in Children Initially Presenting with Acute Disseminated Encephalomyelitis (ADEM) (2021) (0)
- AMP-activated protein kinase suppresses autoimmune CNS disease by regulating M1 type macrophage-Th17 axis (IRC5P.474) (2014) (0)
- Neural Degeneration and Potential Novel Treatments (2013) (0)
- Table 2, IgM induced Ca2+ response correlates with the ability to promote remyelination (2013) (0)
- An Abbreviated Exposure to Chronic Hypoxia is Sufficient to Induce CNS Hypomyelination and Impair Motor Development in Neonatal Mice (P6.013) (2014) (0)
- A recombinant human IgM prevents neuronal injury in multiple animal models of CNS disease (2013) (0)
- PATTERNS OF MULTIPLE SCLEROSIS IMMUNOPATHOLOGY (1998) (0)
- functional role of B-cell receptor Clonal evolution in Waldenstrom macroglobulinemia highlights (2013) (0)
- Intrinsic upregulation of critical innate immune effectors in a novel transgenic mouse model confers viral resistance (P1389) (2013) (0)
- Immunotherapies using Conventional and Natural Antibodies for the Treatment of Multiple Sclerosis ( Ms ) Immunosuppressive and immunomodulatory therapeutic approaches for MS (2016) (0)
- Reply (1993) (0)
- CD4 1 T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice (2004) (0)
- Demyelination Virus-Induced Central Nervous System Pathogenesis of Autoimmune and Differential Influence of Interleukin-12 in the (1998) (0)
- -Transgenic Mice a Lymphocytes in 4-1BB (CD137) Ligand/I-E Progressive Depletion of Peripheral B (2001) (0)
- Dual role of CD8+ T cells in PLPp91-110 induced experimental autoimmune encephalomyelitis in HLA-DR3.Abo transgenic mice (99.1) (2009) (0)
- Human gut-derived commensal Prevotella histicola suppress experimental autoimmune encephalomyelitis in humanized mice (2017) (0)
- The Causal Effect of Serum Vitamin D Levels on Pediatric Multiple Sclerosis: A Mendelian Randomization Study (S29.007) (2016) (0)
- THE ROLE OF PERFORIN AND FAS-MEDAITED CYTOTOXIC EFFECTOR FUNCTION IN THE DEVELOPMENT OF DEMYELINATION AND NEUROLOGIC DEFICITS IN A VIRAL MODEL OF MULTIPLE SCLEROSIS (1998) (0)
- Dendritic Cells Uptake and Retention in Mature Myeloid TREM-2 Mediated Signaling Induces Antigen (2017) (0)
- Obtaining Patient and Family Views in Pediatric MS Research Needs, Outcomes and Methods: Study Design (P2.129) (2016) (0)
- Epidemiology of MS (1991) (0)
- Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis (2023) (0)
- Diagnosis and Management of Multiple Sclerosis (2003) (0)
- Poster Session CP3: Spinal Cord Injury, Axonal Regeneration, Plasticity (2004) (0)
- A monoclonal natural human IgM protects axons in the absence of remyelination (2016) (0)
- Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited. (S10.003) (2017) (0)
- F.32. HLA-DQ8 (DQB1*0302) Molecule Modulate PLP91-110 Induced EAE in HLA-DR3 (DRB1*0301)/DQ8 Double Transgenic Mice through Pro-inflammatory Cytokine IL-17 (2008) (0)
- Standardization of a DNA test to detect Porcine Stress Syndrome (PSS) in Cuban swine (2005) (0)
- Physical trauma and multiple sclerosis (1994) (0)
- PHYSICAL TRAUMA AND MULTIPLE SCLEROSIS. REPLY (1994) (0)
- H-2K-Restricted Virus-Specific Cytotoxicity Protein Inhibits the Generation of A Theiler's Virus Alternatively Initiated (1998) (0)
- Biomarkers in radiologically isolated syndrome: The missing piece in the puzzle of treatment indication? (2017) (0)
- A new look at cognitive functioning in pediatric MS (2022) (0)
- Comprar Advances in Multiple Sclerosis and Experimental Demyelinating Diseases | Rodriguez, Moses | 9783540736769 | Springer (2008) (0)
- Erratum: Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC (The FASEB Journal (2006) 20, 13 (2408-2410) DOI: 10.1096/fj.06-6171fje) (2010) (0)
- Rat spinal model for meningeal carcinomatosis and for assessing central nervous system (CNS) toxicity of anti-cancer drugs administered intrathecally (1985) (0)
- Neuropathology: Clues to Pathogenesis (2013) (0)
- Polyclonal Ig: an immunopharmacon? (1994) (0)
- Mapping o f the Gene Within the H-2 D Region BY (2003) (0)
- Th 17 Axis − Disease by Regulating M 1-Type Macrophage Autoimmune Central Nervous System AMP-Activated Protein Kinase Suppresses (2016) (0)
- Silent findings: Examination of asymptomatic demyelination in a pediatric US cohort. (2023) (0)
- Results Gut Microbiota of RRMS Patients Differs from Healthy controls (2019) (0)
- Predicting Tempo of Post-Progression Disability Accumulation in Multiple Sclerosis (P02.147) (2013) (0)
- Patterns of Use and Safety of Newer Disease-modifying therapies in Pediatric Multiple Sclerosis in the US (S51.004) (2018) (0)
- EBV, CMV, and HSV IgG Titers Are Not Predictive of Subsequent Relapse Risk in Pediatric Multiple Sclerosis (P02.096) (2012) (0)
- Future Disease-Modifying Treatment Approaches in Multiple Sclerosis (2013) (0)
- Multiple Sclerosis and Related Disorders (2016) (0)
- Plasmonic nanopore arrays for characterizing the binding of myelin growth promoting igm antibodies to supported lipid bilayers (2011) (0)
- Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder (2022) (0)
- Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals (2005) (0)
- T cells protect from demyelinating disease in a viral model of multiple sclerosis (2000) (0)
- Identification of genes/pathways responsible for resistance vs susceptibility to EAE utilizing HLA class-II transgenic mice (BA8P.163) (2015) (0)
- Monoclonal antibodies that promote remyelination of the central nervous system. (1995) (0)
- The role of natural autoantibodies in myelin repair (1998) (0)
- Human Antibody B7-Dendritic Cell (PD-L2) Cross-Linking Following Systemic Treatment with a Blockade of Allergic Airway Inflammation (2004) (0)
- Demographic and Clinical Characteristics of 490 Children and Adolescents with Multiple Sclerosis (MS): US Network of Pediatric MS Centers’ Experience (S29.004) (2016) (0)
- Lipid-specific IgMs induce antiviral responses in the CNS: implications for progressive multifocal leukoencephalopathy in multiple sclerosis (2020) (0)
- Enumeration of T-lymphocyte subsets, B-cells and macrophages in CNS of susceptible mice infected with Theiler's virus (1987) (0)
- Journal of Neurology & Translational Neuroscience (0)
- Menarche and Relapses in Girls with Pediatric Multiple Sclerosis (1270) (2020) (0)
- Absence of IFNγ increased brain pathology in EAE-susceptible DR3DQ8 HLA transgenic mice through secretion of IL-17 and induction of pathogenic monocytes/microglia into the CNS (BA14P.202) (2014) (0)
- HEALTH CARE UTILIZATION IN MS. AUTHORS' REPLY (1999) (0)
- SYMPOSIUM: New Disease Mechanisms in Multiple Sclerosis (2007) (0)
- Human Antibody B 7-Dendritic Cell ( PD-L 2 ) Cross-Linking Following Systemic Treatment with a Blockade of Allergic Airway Inflammation (2004) (0)
- Introduction (0)
- Managing Symptoms of Multiple Sclerosis (2013) (0)
- MEASURING BINDING INTERACTIONS OF NEURITE-EXTENSION PROMOTING ANTIBODIES TO SUPPORTED LIPID MEMBRANES USING A MULTICHANNEL MICROFLUIDIC PLASMONIC NANOHOLE ARRAY BIOSENSOR (2013) (0)
- A novel method for the quantification of spinal cord damage in a murine viral model of multiple sclerosis (1998) (0)
- The Spectrum and Diagnosis of Multiple Sclerosis (2013) (0)
- ULTRASTRUCTURAL LOCALIZATION OF VIRAL ANTIGEN IN MICE PERSISTENTLY INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV): 77 (1982) (0)
- Enhancing CNS Repair in Neurological Disease Arising from Neurodegeneration and (2011) (0)
- HLA Transgenic Mice Susceptible − Encephalomyelitis in Experimental Autoimmune Increases Brain Pathology (2014) (0)
- Kallikrein 6, a degradative serine proteinase, is expressed by glioblastoma cells in vivo (2004) (0)
- HLA-Dr is critical for the induction of EAE, while HLA-DQ can modulate the severity of disease: Studies in HLA transgenic mice (1998) (0)
- Environmental Risk Factors Associated with Pediatric Neuromyelitis Optica (P02.157) (2013) (0)
- RBIO-03. HETEROGENEITY OF HUMAN PATIENT-DERIVED XENOGRAFTS GROWTH RATES RESPONSES TO THE RADIATED MICROENVIRONMENT (2020) (0)
- Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625) (2020) (0)
- MONOCLONAL ANTIBODIES STIMULATE REMYELINATION IN A VIRAL MODEL OF MULTIPLE SCLEROSIS (1993) (0)
- Strategies to Promote Central Nervous System Remyelination In Vivo (1997) (0)
- The role of complex IV activity in the axonal response of mitochondria to demyelination in experimental disease models of multiple sclerosis (2021) (0)
- Treatment to Promote Remyelination (2013) (0)
- Differential ability of H-2 class Ia genes to effectively direct anti viral immunity (105.53) (2012) (0)
- Raymond Adams: A Life of Mind and Muscle (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Moses Rodriguez?
Moses Rodriguez is affiliated with the following schools:
